What is the newest antibiotic for C. diff? Unpacking the latest treatments and innovations
•
4 min read
While fidaxomicin (Dificid), approved in 2011, is still the most recently approved *targeted* antibiotic for *Clostridioides difficile* (C. diff), recent advancements have focused more on preventing recurrent infections rather than developing new antibiotics. For those asking what is the newest antibiotic for C. diff, the answer involves understanding that the latest innovations are actually non-antibiotic, microbiome-based therapies.
